Haemophilus Vaccines

Known as: Haemophilus Vaccines [Chemical/Ingredient], Hemophilus Vaccines, Vaccines, Hemophilus 
Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2017
02419872017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
We characterized cytokine profiles of CD4(+) T-helper (h) cells in adults and young children to ascertain if responses occur to… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
An outer membrane protein of nontypeable Haemophilus influenzae (NTHi), P6, is a vaccine candidate because it has been… (More)
Is this relevant?
2007
2007
n engl j med 357;13 www.nejm.org september 27, 2007 1278 I 1997, Frank Pallone, a U.S. congressman from New Jersey, attached a… (More)
Is this relevant?
2006
2006
OBJECTIVES To describe the characteristics of pneumococcal isolates obtained from patients with invasive pneumococcal disease in… (More)
Is this relevant?
2005
2005
Two studies were undertaken to investigate the concomitant administration of combined hepatitis A/B vaccine with a diphtheria… (More)
Is this relevant?
2000
2000
OBJECTIVE Environmental factors have been suggested to play an important role in the pathogenesis of type 1 diabetes. The aim of… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1997
1997
Haemophilus influenzae has been a major cause of infectious diseases in children and has been attributed as a significant cause… (More)
Is this relevant?
1994
1994
The safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate (PRP-T) administered concurrently in… (More)
Is this relevant?
1991
1991
Sixty-four patients with chronic bronchitis with a history of recurrent respiratory tract infections were admitted to a double… (More)
Is this relevant?
1989
1989
The Haemophilus influenzae type b polysaccharide vaccine was licensed for use in the United States in April 1985. Postlicensure… (More)
Is this relevant?